| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 |
| filingDate |
1999-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4af89b6cf527d1ddc25abb0e7f1d320
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15c120af93d7d94687a42ecd6149ce62 |
| publicationDate |
2001-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-20004355-A3 |
| titleOfInvention |
Pharmaceutical preparation |
| abstract |
The present invention relates to a spontaneously dispersing pharmaceutical composition comprising a piperidine substance P antagonist. The composition is useful for treating central nervous system disorders such as depression and social phobia and respiratory diseases such as asthma or chronic bronchitis. |
| priorityDate |
1999-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |